Simpson Jennifer K. Insider Trades

Insider Trading History

Track insider trading activity for Simpson Jennifer K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $808 72,800 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.4k 72,800 shares
$0.39
$0.01
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $1.1k 99,383 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.9M 99,383 shares
$300.84
$0.01
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $8.53k 16,253 shares
Last Trade
Mar 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 16,253 shares
$26.00
$0.52
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $98.7 8,888 shares
Last Trade
Jan 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.2M 13,332 shares
$918.00
$0.01
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $5.88k 11,200 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$531k 11,200 shares
$47.39
$0.52
CytRx
CytRx CYTR
Director
Holding Value $4.5k 50,000 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.5k 50,000 shares
$0.45
$0.09
CytRx
CytRx CYTR
Director
Holding Value $2.25k 25,000 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.3k 25,000 shares
$0.45
$0.09
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $212 19,125 shares
Last Trade
Sep 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2k 19,125 shares
$2.26
$0.01
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $1.89k 170,000 shares
Last Trade
Mar 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$695k 170,000 shares
$4.09
$0.01
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $7.09k 13,500 shares
Last Trade
Feb 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 13,500 shares
$49.32
$0.52
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $38 3,424 shares
Last Trade
Sep 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.01
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $26.9 2,424 shares
Last Trade
Sep 01, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.01
Panbela Therapeutics
Panbela Therapeutics PBLA
President And CEO
Holding Value $2.35k 212,048 shares
Last Trade
Jul 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Delcath Systems
Delcath Systems DCTH
President And CEO
Holding Value $0 0 shares
Last Trade
May 08, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.18k 147 shares
$8.00
$10.79
Delcath Systems
Delcath Systems DCTH
President And CEO
Holding Value $270k 25,021 shares
Last Trade
May 08, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$118k 14,700 shares
$8.00
$10.79
Delcath Systems
Delcath Systems DCTH
President And CEO
Holding Value $111k 10,321 shares
Last Trade
May 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.1k 10,310 shares
$8.25
$10.79
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $5.25k 10,000 shares
Last Trade
Jan 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 10,000 shares
$59.80
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
Director
Holding Value $5.25k 10,000 shares
Last Trade
Oct 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 10,000 shares
$58.88
$0.52
Delcath Systems
Delcath Systems DCTH
President And CEO
Holding Value $26.4M 2,450,000 shares
Last Trade
Jul 15, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$245k 2,450,147 shares
$0.10
$10.79
Delcath Systems
Delcath Systems DCTH
Director, President & CEO
Holding Value $3.78M 350,000 shares
Last Trade
Feb 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35k 350,000 shares
$0.10
$10.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up